{"sentence_labels": [-1, -1, 1, -1], "text": "As described previously [8] , 100 children 6-59 months old with malaria (positive Giemsa smear and T>37.5\u02daC) and hemoglobin 5.0-9.9 g/dL were enrolled in a randomized trial of iron therapy at Mulago Hospital in Kampala, Uganda (Fig 1) . Children were treated for malaria with parenteral artesunate and also given a 3-day course of oral artemether-lumefantrine. If children had a zinc protoporphyin (ZPP) concentration > = 80 \u03bcmol/mol heme, they were randomized either to begin a 27-day iron therapy regimen (2 mg/kg/day as liquid oral ferrous sulfate) concurrently with antimalarial treatment on Day 0 (immediate group, n = 50) or 28 days later on Day 28 (delayed group, n = 50). Children were given an insecticide-treated bednet and were followed for 56 days (Day 0 -Day 56).", "section": "Study population", "classification_label": 0, "section_number": 5, "sentences": ["As described previously [8] , 100 children 6-59 months old with malaria (positive Giemsa smear and T>37.5\u02daC) and hemoglobin 5.0-9.9 g/dL were enrolled in a randomized trial of iron therapy at Mulago Hospital in Kampala, Uganda (Fig 1) .", "Children were treated for malaria with parenteral artesunate and also given a 3-day course of oral artemether-lumefantrine.", "If children had a zinc protoporphyin (ZPP) concentration > = 80 \u03bcmol/mol heme, they were randomized either to begin a 27-day iron therapy regimen (2 mg/kg/day as liquid oral ferrous sulfate) concurrently with antimalarial treatment on Day 0 (immediate group, n = 50) or 28 days later on Day 28 (delayed group, n = 50).", "Children were given an insecticide-treated bednet and were followed for 56 days (Day 0 -Day 56)."], "doc_id": "39515"}